Search - tctmd.com

Displaying 1 - 20 of 746

Sort: Relevancy | Date

News Conference News ACC 2026

Financial Support After Hospital Discharge Boosts HFrEF Outcomes: FUND-HF

L.A. McKeown

April 08, 2026

News Daily News

African Patients and Trialists Largely Left Out of CV Research

L.A. McKeown

April 06, 2026

News Conference News ACC 2026

Sirolimus DCB in Peripheral Disease Makes Strides in Hard Outcomes: SirPAD

L.A. McKeown

April 02, 2026

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

Caitlin E. Cox

March 30, 2026

News Industry News

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

March 30, 2026

News Daily News

Two Conduction-System Pacing RCTs Give Conflicting Results

Todd Neale

March 20, 2026

LAAO Doesn’t Match Medical Therapy for High-risk AF Patients: CLOSURE-AF

News Conference News

Now Published: LAAO Doesn’t Match Medical Therapy for High-risk AF Patients in CLOSURE-AF

Caitlin E. Cox

March 18, 2026

News Conference News CRT 2026

CARPOOL Radial Access as Good as Femoral in PAD Procedures

L.A. McKeown

March 16, 2026

News Daily News

Digital Data May Sway Intensive BP Treatment in the Elderly

L.A. McKeown

March 09, 2026

News Conference News THT 2026

Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought

Todd Neale

March 04, 2026

Presentation THT 2026

Healthcare Systems Harnessing Their Own Data for Evidence, Generation, Dissemination, and Influencing Clinical Practice — Example 2

Presenter: Nir Uriel

March 04, 2026

Presentation THT 2026

How Will Guideline Committees View Results From RWE Trials?

Presenter: Paul Heidenrich

March 04, 2026

Presentation THT 2026

AHA and C3TN Shock Networks

Presenter: Shashank Shekhar Sinha

March 04, 2026

Presentation THT 2026

Cardiogenic Shock Working Group: Triumphs and Tribulations

Presenter: Rachna Kataria

March 04, 2026

Presentation THT 2026

Hemodynamic Frontiers in Heart Failure (HF2) Registry: Goals and Achievements

Presenter: Tom Heywood

March 04, 2026

Presentation THT 2026

Virtual Randomized Clinical Trials: Learnings From DANLOGIC-HF

Presenter: Tor Biering-Sørensen

March 04, 2026

Presentation THT 2026

Statistical Approaches for Developing Credible Evidence of Safety and Effectiveness for HF Devices From Real World Data: An Overview for the Clinician

Presenter: Issa Dahabreh

March 04, 2026

Presentation THT 2026

Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion

Presenter: Robert W. Yeh

March 04, 2026

News Daily News

Meta-analysis Teases Out What Drives Success in M-TEER

Caitlin E. Cox

February 10, 2026

News Conference News STS 2026

Multiarterial CABG Improves Survival Regardless of Strategy

Yael L. Maxwell

February 02, 2026

Advertisement

Financial Support After Hospital Discharge Boosts HFrEF Outcomes: FUND-HF

African Patients and Trialists Largely Left Out of CV Research

Sirolimus DCB in Peripheral Disease Makes Strides in Hard Outcomes: SirPAD

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

Two Conduction-System Pacing RCTs Give Conflicting Results

Now Published: LAAO Doesn’t Match Medical Therapy for High-risk AF Patients in CLOSURE-AF

CARPOOL Radial Access as Good as Femoral in PAD Procedures

Digital Data May Sway Intensive BP Treatment in the Elderly

Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought

Healthcare Systems Harnessing Their Own Data for Evidence, Generation, Dissemination, and Influencing Clinical Practice — Example 2

How Will Guideline Committees View Results From RWE Trials?

AHA and C3TN Shock Networks

Cardiogenic Shock Working Group: Triumphs and Tribulations

Hemodynamic Frontiers in Heart Failure (HF2) Registry: Goals and Achievements

Virtual Randomized Clinical Trials: Learnings From DANLOGIC-HF

Statistical Approaches for Developing Credible Evidence of Safety and Effectiveness for HF Devices From Real World Data: An Overview for the Clinician

Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion

Meta-analysis Teases Out What Drives Success in M-TEER

Multiarterial CABG Improves Survival Regardless of Strategy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content